Praxis Precision Medicines, Inc.
PRAX
$366.81
-$1.65-0.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -10.99% | 0.62% | |||
| Gross Profit | 10.99% | -0.62% | |||
| SG&A Expenses | -1.38% | 42.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.46% | 9.08% | |||
| Operating Income | 8.46% | -9.08% | |||
| Income Before Tax | 9.55% | -4.11% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 9.55% | -4.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 9.55% | -4.11% | |||
| EBIT | 8.46% | -9.08% | |||
| EBITDA | 8.46% | -9.08% | |||
| EPS Basic | 10.32% | 8.43% | |||
| Normalized Basic EPS | 10.95% | 11.36% | |||
| EPS Diluted | 10.32% | 8.43% | |||
| Normalized Diluted EPS | 10.95% | 11.36% | |||
| Average Basic Shares Outstanding | 0.86% | 13.68% | |||
| Average Diluted Shares Outstanding | 0.86% | 13.68% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||